These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8498828)

  • 1. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
    Eidelberg D; Takikawa S; Moeller JR; Dhawan V; Redington K; Chaly T; Robeson W; Dahl JR; Margouleff D; Fazzini E
    Ann Neurol; 1993 May; 33(5):518-27. PubMed ID: 8498828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
    De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM
    Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
    Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
    Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic topography of parkinsonism.
    Eidelberg D; Moeller JR; Dhawan V; Spetsieris P; Takikawa S; Ishikawa T; Chaly T; Robeson W; Margouleff D; Przedborski S
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):783-801. PubMed ID: 8063874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
    Burn DJ; Rinne JO; Quinn NP; Lees AJ; Marsden CD; Brooks DJ
    Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.
    Eidelberg D; Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Robeson W; Dahl JR; Margouleff D
    J Nucl Med; 1995 Mar; 36(3):378-83. PubMed ID: 7884498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Striatonigral degeneration].
    Mochizuki A; Shimizu T
    Nihon Rinsho; 1997 Jan; 55(1):123-6. PubMed ID: 9014434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic topography of normal aging.
    Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Mandel F; Alexander GE; Grady C; Pietrini P; Eidelberg D
    J Cereb Blood Flow Metab; 1996 May; 16(3):385-98. PubMed ID: 8621743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Giladi N; Takikawa S; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Fahn S; Eidelberg D
    Neurology; 1994 Sep; 44(9):1622-8. PubMed ID: 7936286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
    Sasaki M; Ichiya Y; Hosokawa S; Otsuka M; Kuwabara Y; Fukumura T; Kato M; Goto I; Masuda K
    Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.
    Eidelberg D; Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Silbersweig D; Stern E; Woods RP; Fazzini E; Dogali M; Beric A
    Ann Neurol; 1996 Apr; 39(4):450-9. PubMed ID: 8619523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
    Piccini P; Turjanski N; Brooks DJ
    J Neural Transm Suppl; 1995; 45():123-31. PubMed ID: 8748617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
    Eidelberg D; Moeller JR; Dhawan V; Sidtis JJ; Ginos JZ; Strother SC; Cedarbaum J; Greene P; Fahn S; Rottenberg DA
    Mov Disord; 1990; 5(3):203-13. PubMed ID: 2117706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.